Ligand receives US$ 6.5 mn from Roche for progression of RG7348 into phase-I trial in treatment of HCV infection

Ligand receives US$ 6.5 mn from Roche for progression of RG7348 into phase-I trial in treatment of HCV infection
Ligand Pharmaceuticals Incorporated announced that it earned a US$ 6.5 million payment from Roche as a result of Roche progressing RG7348 into a phase-I clinical trial for the treatment of hepatitis C viral (HCV) infection.
Read more on [...]

Nationwide Phase III clinical trial of OncoVEX for advanced melanoma

Nationwide Phase III clinical trial of OncoVEX for advanced melanoma
Rush University Medical Center is leading a nationwide Phase III clinical trial to determine whether a promising vaccine for advanced melanoma can effectively treat the deadly skin cancer.
Read more on News-Medical-Net

CBio Secures Another Clinical Trial Milestone

CBio Secures Another Clinical Trial Milestone
Australian drug development company CBio Limited (ASX: CBZ) today announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S.
Read more on BioresearchOnline